Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

NICE approves psoriasis drug

  • Comment
NICE has approved adalimumab (Humira) for use as a treatment for chronic plaque psoriasis in adults.

It is currently the only fully human anti-TNF monoclonal antibody licensed for treating plaque psoriasis in the UK.

The drug was recommended by NICE for treating severe active ankylosing spondylitis in May, and it was approved in Scotland for psoriasis last month.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.